Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702115 | Journal of Thoracic Oncology | 2016 | 28 Pages |
Abstract
These results demonstrate the implication of CCL2 in MPM pathogenesis and designate M-CSF as a new potential biomarker of MPM. This study also identifies CCL2 and colony-stimulating factor 1 receptor/M-CSF as interesting new targets to modulate pro-tumorigenic properties of the tumor microenvironment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Anne-Laure MD, Sènan PhD, Thibaut MS, Julie PhD, Sophie Deshayes, Jean-François PhD, Laurent MD, Yves PhD, Marc PhD, Christophe PhD,